381 related articles for article (PubMed ID: 35572649)
1. Hepatocellular Carcinoma: How the Gut Microbiota Contributes to Pathogenesis, Diagnosis, and Therapy.
Luo W; Guo S; Zhou Y; Zhao J; Wang M; Sang L; Chang B; Wang B
Front Microbiol; 2022; 13():873160. PubMed ID: 35572649
[TBL] [Abstract][Full Text] [Related]
2. Gut Microbiota and Hepatocellular Carcinoma.
Tao X; Wang N; Qin W
Gastrointest Tumors; 2015 May; 2(1):33-40. PubMed ID: 26673641
[TBL] [Abstract][Full Text] [Related]
3. Targeting gut microbiota in hepatocellular carcinoma: probiotics as a novel therapy.
Wan MLY; El-Nezami H
Hepatobiliary Surg Nutr; 2018 Feb; 7(1):11-20. PubMed ID: 29531939
[TBL] [Abstract][Full Text] [Related]
4. The Gut Microbiome and Hepatocellular Carcinoma: Implications for Early Diagnostic Biomarkers and Novel Therapies.
Kang Y; Cai Y; Yang Y
Liver Cancer; 2022 Apr; 11(2):113-125. PubMed ID: 35634424
[TBL] [Abstract][Full Text] [Related]
5. Potential tactics with certain gut microbiota for the treatment of unresectable hepatocellular carcinoma.
Yoshikawa S; Taniguchi K; Sawamura H; Ikeda Y; Asai T; Tsuji A; Matsuda S
Explor Target Antitumor Ther; 2023; 4(4):556-568. PubMed ID: 37720344
[TBL] [Abstract][Full Text] [Related]
6. Unveiling the complex relationship between gut microbiota and liver cancer: opportunities for novel therapeutic interventions.
Rajapakse J; Khatiwada S; Akon AC; Yu KL; Shen S; Zekry A
Gut Microbes; 2023 Dec; 15(2):2240031. PubMed ID: 37615334
[TBL] [Abstract][Full Text] [Related]
7. Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites.
Zhang X; Coker OO; Chu ES; Fu K; Lau HCH; Wang YX; Chan AWH; Wei H; Yang X; Sung JJY; Yu J
Gut; 2021 Apr; 70(4):761-774. PubMed ID: 32694178
[TBL] [Abstract][Full Text] [Related]
8. Research progress of gut microbiota in hepatocellular carcinoma.
Li K; Liu J; Qin X
J Clin Lab Anal; 2022 Jul; 36(7):e24512. PubMed ID: 35719048
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment.
Spanu D; Pretta A; Lai E; Persano M; Donisi C; Mariani S; Dubois M; Migliari M; Saba G; Ziranu P; Pusceddu V; Puzzoni M; Astara G; Scartozzi M
World J Hepatol; 2022 Jul; 14(7):1319-1332. PubMed ID: 36158925
[TBL] [Abstract][Full Text] [Related]
10. Berberine activates PPARδ and promotes gut microbiota-derived butyric acid to suppress hepatocellular carcinoma.
Shou JW; Shaw PC
Phytomedicine; 2023 Jul; 115():154842. PubMed ID: 37148713
[TBL] [Abstract][Full Text] [Related]
11. Understanding gut dysbiosis for hepatocellular carcinoma diagnosis and treatment.
Yu J; Chen X; Yang X; Zhang B
Trends Endocrinol Metab; 2024 Jul; ():. PubMed ID: 38969601
[TBL] [Abstract][Full Text] [Related]
12. Gut Microbiota, Peroxisome Proliferator-Activated Receptors, and Hepatocellular Carcinoma.
Yu Q; Wu L; Ji J; Feng J; Dai W; Li J; Wu J; Guo C
J Hepatocell Carcinoma; 2020; 7():271-288. PubMed ID: 33150145
[TBL] [Abstract][Full Text] [Related]
13. Role of Gut Microbiota in Hepatocarcinogenesis.
Gupta H; Youn GS; Shin MJ; Suk KT
Microorganisms; 2019 May; 7(5):. PubMed ID: 31060311
[TBL] [Abstract][Full Text] [Related]
14. The gut microbiome and liver cancer: mechanisms and clinical translation.
Yu LX; Schwabe RF
Nat Rev Gastroenterol Hepatol; 2017 Sep; 14(9):527-539. PubMed ID: 28676707
[TBL] [Abstract][Full Text] [Related]
15. Altered gut microbiota in hepatocellular carcinoma: Insights into the pathogenic mechanism and preclinical to clinical findings.
Das BK
APMIS; 2022 Dec; 130(12):719-740. PubMed ID: 36321381
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and therapeutic potential of the gut microbiota in patients with early hepatocellular carcinoma.
Ponziani FR; Nicoletti A; Gasbarrini A; Pompili M
Ther Adv Med Oncol; 2019; 11():1758835919848184. PubMed ID: 31205505
[TBL] [Abstract][Full Text] [Related]
17. The Potential Gut Microbiota-Mediated Treatment Options for Liver Cancer.
Zhang C; Yang M; Ericsson AC
Front Oncol; 2020; 10():524205. PubMed ID: 33163393
[TBL] [Abstract][Full Text] [Related]
18. Potential predictive role of gut microbiota to immunotherapy in HCC patients: a brief review.
Muscolino P; Granata B; Omero F; De Pasquale C; Campana S; Calabrò A; D'Anna F; Drommi F; Pezzino G; Cavaliere R; Ferlazzo G; Silvestris N; Speranza D
Front Oncol; 2023; 13():1247614. PubMed ID: 37692859
[TBL] [Abstract][Full Text] [Related]
19. Utilizing Gut Microbiota to Improve Hepatobiliary Tumor Treatments: Recent Advances.
Qin H; Yuan B; Huang W; Wang Y
Front Oncol; 2022; 12():924696. PubMed ID: 35924173
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the Gut Microbiome to Improve Clinical Outcomes in Hepatocellular Carcinoma.
Shen S; Khatiwada S; Behary J; Kim R; Zekry A
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
